The efficacy of traditional Chinese medicine in the treatment of covid-19 has been recognized by the WHO. The products of the two pharmaceutical companies have been used for epidemic prevention and control in Shanghai and other places
[Securities Times] it is reported that the efficacy of traditional Chinese medicine in the treatment of covid-19 pneumonia has been recognized by the WHO expert meeting. The report of “who expert evaluation meeting on the treatment of covid-19 pneumonia with traditional Chinese medicine” was released on the official website of who on March 31. 21 international experts from six regions of who participated in the evaluation meeting. The meeting report pointed out that traditional Chinese medicine can effectively treat covid-19 pneumonia, reduce the conversion of mild and common cases to severe cases, shorten the virus clearance time and improve the clinical prognosis of mild and common patients. The report also encourages Member States to consider the integrated medical model (Integrated Traditional Chinese and Western medicine model) formed and applied in China; Effectively manage the current epidemic and prepare for a possible pandemic in the future.
Comments: with the spread of covid-19 epidemic, the therapeutic effect of traditional Chinese medicine has been widely recognized in the industry. At present, more than 19 cities in China have been deeply involved in the prevention and treatment of pneumonia with traditional Chinese medicine. Previously, the national joint prevention and control mechanism “covid-19 guidelines for TCM Prevention and control of pneumonia aggregation epidemic” clearly pointed out that it is necessary to adhere to the principle of “moving the gate forward, sinking the center of gravity, early intervention and whole process intervention” of traditional Chinese medicine, and fully implement TCM Intervention for diagnosed, asymptomatic patients and key control personnel. More and more successful treatment cases have proved that the intervention effect of traditional Chinese medicine is significant and plays an irreplaceable role in the prevention and control of covid-19 pneumonia. As the efficacy of traditional Chinese medicine in the treatment of covid-19 pneumonia has been recognized by who, Chinese traditional medicine is expected to usher in more opportunities in covid-19 treatment and other fields, and companies in relevant fields will benefit.
Jilin Aodong Pharmaceutical Group Co.Ltd(000623) ( Jilin Aodong Pharmaceutical Group Co.Ltd(000623) ): as of March 30, 2022, according to the requirements of the leading group of New Coronavirus disease prevention and control at all levels in Jilin, prefectures and municipalities, the company has provided about 1 million 210 thousand products of Chinese medicine decoction and granules, and the following companies will do well in product supply according to epidemic prevention.
Shanghai Kaibao Pharmaceutical Co.Ltd(300039) ( Shanghai Kaibao Pharmaceutical Co.Ltd(300039) ): Tanreqing injection, the main product of the company, has been listed as a “New Coronavirus pneumonia diagnosis and treatment plan (Trial sixth / seven / eight / nine Edition)” in the clinical treatment period (confirmed cases). It has been recommended by Beijing, Shanghai, Guangdong and other provinces and cities in the list of New Coronavirus pneumonia TCM treatment programs.
